The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...

Already, significant harm has been done to inhibit progress combating HIV/AIDS, and the next four years could return us to ...

The United States’ shutdown of HIV/Aids funding may harm global Aids programmes irreparably, jeopardising millions of lives ...

The availability of effective antiretroviral therapy has lowered the risk, and the severity, of neural sequelae of HIV infection. “Early in the HIV pandemic, approximately 15% of people with HIV had ...

Thankfully, in 2025, the days of lockdowns and quarantines now seem a distant memory for many—even though the physical, ...

An American biochemist whose research has helped scientists make inroads on treating coronavirus and HIV has won this year’s ...

The PETITE study is evaluating two formulations of dolutegravir in newborn babies under 4 weeks of age – an oral film. In the ...

On March 11 2020, as COVID continued to spread rapidly around the globe, the World Health Organization (WHO) officially ...

CRISPR technology offers innovative solutions for pandemic preparedness, enhancing diagnostics, antiviral therapies, and ...

COVID-19 took the lives of more than one million Americans and nearly 116,000 Californians, according to the Centers for Disease Control and Prevention.

HIV is not like TB. While TB treatment takes six long months ... We have already lost so much ground during the COVID-19 pandemic. An estimated 700,00 TB deaths stemmed from the disruptions caused by ...